-
Oil crops
Time of Update: 2021-03-05
plants are cultivated annually or more years after the main purpose of harvesting seed oil.
can also be used to extract oil.
-
AstraZeneta wants to buy Gilead's largest biopharmaceutical merger
Time of Update: 2021-03-05
afternoon of June 7, AstraZeneta was in contact with Gilead Sciences about a possible merger that, if successful, would be the largest medical deal in history, involving $96 billion, according to people familiar with the matter.
-
From "buy, buy" to "naturalized" listed pharmaceutical companies experienced what?
Time of Update: 2021-03-05
biology, Kangzhi Pharmaceuticals and other listed companies announced the sale of assets. Four Rings Bio announced on December 13, 2019 that its wholly-owned subsidiary Guangxi InterContinental Forestry Investment Co., Ltd. announced
-
China National Offshore Oil and Sinopec to strengthen the lubricant industry
Time of Update: 2021-03-05
Upon completion, the oil and gas development and utilization company will have a production capacity of 1.05 million tons/year of lubricant base oil, becoming a producer and supplier of high-quality paraffin-based and cyclane-based lubricant base oils.
-
How to let paint customers buy "expensive" and feel that buy "value"
Time of Update: 2021-03-05
9, customers want to bargain to understand the real price of the product, to experience whether the marketer is lying.
-
Takeda Pharmaceuticals, the pharmaceutical industry's "snake swallowing elephant," will buy Shire for $58 billion
Time of Update: 2021-03-04
On December 5, local time, Takeda, the Japanese pharmaceutical group, announced the results of a shareholder meeting in which Takeda's shareholders approved the acquisition of Shire, the British maker of rare diseases.
-
Changchun High-new premium 12.76 times to buy a 29.5% stake in Kinsey Pharmaceuticals
Time of Update: 2021-03-03
At the same time, Changchun Gaoxin intends to raise matching funds by non-publicly issuing shares or convertible bonds.
-
Vertex joined Diabetes in buying Semma for $950 million
Time of Update: 2021-03-01
Semma Therapeutics specializes in the treatment of type 1 diabetes using stem cell-derived human islets.
-
Iran nuclear deal or increase the oversupply of crude oil a new round of decline intensified
Time of Update: 2021-03-01
Tehran's nuclear talks could reach an agreement that would allow Iran to export more crude oil, but global supplies of crude oil have continued to rise. Crude oil's recent stability has been fragile, with Brent crude retreating after hitting
-
Britain has agreed to buy Sbach Therapeutics from Roche Pharmaceuticals
Time of Update: 2021-03-01
China's medicine authority said its investigation also identified several innovative non-gene therapy products being developed that could be viable alternatives to Roche and Sbach treatments, ensuring patients had sufficient options in the future and unconditionally approved the move.
-
Kangmei took another county distribution of a number of pharmaceutical companies to buy sanjia hospital
Time of Update: 2021-02-28
experts think that the hospital's public welfare or not and the ownership of the hospital has no absolute relationship. , for example, many social hospitals in the UK are public good, but the government can still fund them. On the other way
-
People's big pharmacy: to buy 1200 pharmacies
Time of Update: 2021-02-28
In order to support the company's expansion of stores, construction of logistics networks and merger and acquisition arrangements in China, The People's Big Pharmacy Chain Co., Ltd.
-
Four billion! Yuheng Pharmaceuticals to buy turnover of 1.44 million yuan company
Time of Update: 2021-02-28
the establishment of Yuheng Jingdong Health Investment Management Co., Ltd. The announcement shows that Yudong Health mainly layout oral chronic disease drug market. February 22, 2016, Yu Heng paid $25 million through its wholly-owned subsidiary, Yu Heng
-
160 million! Yiyi Pharmaceutical intends to buy a house from the real controller and other people to build an orthopaedic hospital
Time of Update: 2021-02-27
operations. The company also stressed that the investment in the new private orthopaedic specialist hospital in line with the company's active expansion of the strategic direction of medical services, after investigation and evaluation, the location
-
Fangsheng Pharmaceuticals decided to buy a 51% stake in Sanhua Pharmaceuticals for $10.2 million
Time of Update: 2021-02-27
and tablets two dosage line, which to dispersal agent "three flower bone dispersion" as the main product. flower bone scattered from the ancient side, has thousands of years of history. Sanhua bone dispersion has experienced a thousand years
-
240,000 tons of central reserve frozen pork has been put in the local market grain and oil meat and egg dishes
Time of Update: 2021-02-27
of grain, oil and eggs, pork, egg prices fell. February 8, the retail prices of pork and eggs in 36 large and medium-sized cities in China were 29.8 yuan and 5.3 yuan per kilogram, respectively, down 2% and 7.6% from their previous highs.
-
Go abroad to buy toilet lid hot discussion paint enterprise upgrade is imminent
Time of Update: 2021-02-27
China Paint Network News: As we all know, before and after the Spring Festival, "go abroad to buy toilet lid" news has not only become the focus of public opinion, domestic consumers far away in Japan to buy domestic toilet lid, rather than
-
Industry advice: home online shopping "can't touch" don't buy
Time of Update: 2021-02-26
China Paint Network : Spring is the decoration season, since March, home appliances manufacturers have launched home improvement building materials products promotion. Online home improvement building materials prices are much lower than
-
Lilley buys Loxo Oncology for $8 billion
Time of Update: 2021-02-26
The acquisition includes the recently approved treatment Vitrakvi, a TRK fusion inhibitor that in November 2018 became the first small molecule approved by the U.S. Food and Drug Administration for the genetic characteristics of cancer patients, not their tumors.
-
Mercer East is proposing to buy Tilos for $773 million
Time of Update: 2021-02-25
previously, some scientists have found that antibodies targeting LAP can prevent the complex from releasing TGF beta, which could lead to new therapies that reduce TGF beta activity.
